Janus Henderson Group PLC Neogenomics Inc Transaction History

Janus Henderson Group PLC

$178 Billion
Q1 2024

A detailed history of Janus Henderson Group PLC transactions in Neogenomics Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 6,280,866 shares of NEO stock, worth $86.1 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

6,280,866

Previous 6,348,613 1.07%

Holding current value

$86.1 Million

Previous $103 Million 3.88%

% of portfolio

0.06%

Previous 0.06%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$14.06 - $16.79 $952,522 - $1.14 Million	-67,747 Reduced 1.07%	6,280,866 $98.7 Million
Q4 2023 Feb 14, 2024	SELL	$11.67 - $20.73 $9.64 Million - $17.1 Million	-825,814 Reduced 11.51%	6,348,613 $103 Million
Q3 2023 Nov 14, 2023	SELL	$12.15 - $17.85 $5.04 Million - $7.41 Million	-415,060 Reduced 5.47%	7,174,427 $88.2 Million
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $2.33 Million - $3.27 Million	165,135 Added 2.22%	7,589,487 $122 Million
Q1 2023 May 15, 2023	BUY	$9.09 - $19.45 $11.8 Million - $25.3 Million	1,298,581 Added 21.2%	7,424,352 $129 Million

Q4 2022 Feb 14, 2023	BUY	$6.45 - $12.07 $1.06 Million - $1.99 Million	164,627 Added 2.76%	6,125,771 $56.6 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $38.6 Million - $63.5 Million	4,915,452 Added 470.07%	5,961,144 $51.3 Million
Q2 2022 Aug 15, 2022	SELL	$7.06 - $13.97 $22.9 Million - $45.3 Million	-3,239,416 Reduced 75.6%	1,045,692 $8.52 Million
Q1 2022 May 16, 2022	SELL	$12.15 - $35.28 $1.25 Million - $3.63 Million	-103,011 Reduced 2.35%	4,285,108 $52.1 Million
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $476,345 - $757,559	15,623 Added 0.36%	4,388,119 $150 Million
Q3 2021 Nov 16, 2021	SELL	$41.66 - $52.52 $2.28 Million - $2.88 Million	-54,742 Reduced 1.24%	4,372,496 $211 Million
Q2 2021 Aug 16, 2021	BUY	$36.62 - $51.69 $11.8 Million - $16.7 Million	323,454 Added 7.88%	4,427,238 $200 Million
Q1 2021 May 17, 2021	BUY	$41.56 - $59.88 $57.6 Million - $83 Million	1,386,761 Added 51.04%	4,103,784 $198 Million
Q4 2020 Feb 16, 2021	BUY	$36.08 - $56.47 $1.33 Million - $2.09 Million	36,992 Added 1.38%	2,717,023 $146 Million
Q3 2020 Nov 16, 2020	SELL	$33.26 - $40.48 $2.03 Million - $2.47 Million	-60,939 Reduced 2.22%	2,680,031 $98.9 Million
Q2 2020 Aug 14, 2020	SELL	$24.21 - $31.02 $1.29 Million - $1.65 Million	-53,299 Reduced 1.91%	2,740,970 $84.9 Million
Q1 2020 May 14, 2020	SELL	$20.5 - $34.53 $13.9 Million - $23.4 Million	-677,771 Reduced 19.52%	2,794,269 $77.2 Million
Q4 2019 Feb 18, 2020	SELL	$18.96 - $29.84 $3.4 Million - $5.35 Million	-179,341 Reduced 4.91%	3,472,040 $102 Million
Q3 2019 Nov 14, 2019	SELL	$19.12 - $26.24 $6.54 Million - $8.97 Million	-341,825 Reduced 8.56%	3,651,381 $69.8 Million
Q2 2019 Jul 31, 2019	SELL	$19.57 - $24.1 $21.7 Million - $26.7 Million	-1,107,082 Reduced 21.71%	3,993,206 $87.6 Million
Q1 2019 Apr 30, 2019	SELL	$12.14 - $20.46 $9.57 Million - $16.1 Million	-788,379 Reduced 13.39%	5,100,288 $104 Million
Q4 2018 Feb 06, 2019	SELL	$11.24 - $18.5 $2.43 Million - $3.99 Million	-215,808 Reduced 3.54%	5,888,667 $74.3 Million
Q3 2018 Nov 09, 2018	SELL	$12.5 - $15.38 $671,625 - $826,367	-53,730 Reduced 0.87%	6,104,475 $93.7 Million
Q2 2018 Aug 10, 2018	SELL	$7.99 - $14.05 $542,592 - $954,121	-67,909 Reduced 1.09%	6,158,205 $80.7 Million
Q1 2018 May 14, 2018	BUY	$7.23 - $8.76 $4.71 Million - $5.71 Million	652,002 Added 11.7%	6,226,114 $50.8 Million
Q4 2017 Feb 09, 2018	BUY	$8.02 - $11.18 $16.9 Million - $23.6 Million	2,109,457 Added 60.89%	5,574,112 $49.4 Million
Q3 2017 Nov 14, 2017	BUY	$9.11 - $11.26 $10.6 Million - $13.1 Million	1,159,888 Added 50.33%	3,464,655 $0
Q2 2017 Aug 17, 2017	BUY	N/A	2,304,767	2,304,767 $20.7 Million

Others Institutions Holding NEO

# of Institutions

279

Shares Held

127M

Call Options Held

1.13M

Put Options Held

232K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.72B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Neogenomics Inc Transaction History